10-Q quarterly report · filed Jul 29, 2026

Humana (HUM) Q2 2026 10-Q Quarterly Report

Short answer

Humana (HUM) filed its Q2 2026 10-Q quarterly report on Jul 29, 2026 for the quarter ended Jun 30, 2026. Quarterly revenue was $40.9B (up 26.2% year over year) with net income of $694M.

Q2 2026 key financials · XBRL

Revenue
$40.9B
+26.2% YoY · +3.1% QoQ
Net income
$694M
+27.3% YoY · −41.5% QoQ
Operating margin
3.3%
EPS (diluted)
$5.72
+26.8% YoY · −41.8% QoQ

Source: XBRL data from the Humana (HUM) Q2 2026 10-Q on SEC EDGAR. USD.

Humana Q2 2026 10-Q analysis

AI summary of MD&A and risk factor updates

Management Discussion & Analysis

  • Total revenue $40.9B, up 26.2% YoY from $32.4B, driven by Insurance premiums
  • Operating margin 3.3% vs 3.4% YoY, with benefit ratio 91.1% vs 89.7%
  • Insurance best-performing segment: revenue $39.0B, up 26.2%; operating income $820M vs $766M
  • Stand-alone PDP strongest product: revenue $3.0B, up 74.0% YoY; state-based contracts weakest, up 1.2%
  • Cash deployment: $908M MaxHealth acquisition; $56M value-creation charges, with additional charges expected
  • Headwinds: BY 2026 Star Ratings, higher new-member benefit ratios, regulatory changes, and anticipated lower favorable claims development

Risk Factors

  • No new risk factors; Humana reported no changes from the 2025 Form 10-K
  • Regulatory and compliance risks remain those disclosed in the 2025 Form 10-K
  • Operational, competitive, and market risks remain unchanged from the 2025 Form 10-K
  • Financial risks remain unchanged from the 2025 Form 10-K

Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K

Other Humana quarterly reports

Ask about this quarter

Compare quarters, check guidance or see what insiders and funds did around the report.